Insufficient scRNA-seq data for expression of CYP7A1 at single-cell level.
Insufficient scRNA-seq data for expression of CYP7A1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 91% | 1521.73 | 206 / 226 | 77% | 75.53 | 311 / 406 |
breast | 98% | 20.60 | 448 / 459 | 0% | 0.01 | 3 / 1118 |
spleen | 98% | 25.47 | 235 / 241 | 0% | 0 | 0 / 0 |
adipose | 97% | 30.20 | 1171 / 1204 | 0% | 0 | 0 / 0 |
uterus | 87% | 9.68 | 148 / 170 | 0% | 0.01 | 1 / 459 |
skin | 72% | 10.25 | 1300 / 1809 | 10% | 0.30 | 49 / 472 |
bladder | 76% | 6.10 | 16 / 21 | 0% | 0 | 0 / 504 |
blood vessel | 75% | 8.07 | 1005 / 1335 | 0% | 0 | 0 / 0 |
lung | 73% | 7.51 | 422 / 578 | 0% | 0.02 | 5 / 1155 |
ovary | 73% | 6.33 | 131 / 180 | 0% | 0.01 | 1 / 430 |
thymus | 72% | 6.61 | 473 / 653 | 0% | 0 | 0 / 605 |
intestine | 68% | 5.83 | 660 / 966 | 2% | 0.05 | 8 / 527 |
prostate | 64% | 4.98 | 158 / 245 | 0% | 0.01 | 2 / 502 |
esophagus | 63% | 5.84 | 906 / 1445 | 2% | 0.04 | 4 / 183 |
adrenal gland | 54% | 3.86 | 139 / 258 | 0% | 0 | 0 / 230 |
stomach | 45% | 3.51 | 162 / 359 | 2% | 0.14 | 6 / 286 |
heart | 47% | 3.10 | 403 / 861 | 0% | 0 | 0 / 0 |
kidney | 46% | 3.53 | 41 / 89 | 0% | 0.09 | 3 / 901 |
brain | 43% | 2.84 | 1147 / 2642 | 0% | 0.00 | 1 / 705 |
muscle | 37% | 2.44 | 301 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 30% | 2.64 | 279 / 929 | 0% | 0 | 0 / 0 |
pancreas | 24% | 1.43 | 79 / 328 | 0% | 0 | 0 / 178 |
eye | 0% | 0 | 0 / 0 | 1% | 0.02 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_0032966 | Biological process | negative regulation of collagen biosynthetic process |
GO_0016125 | Biological process | sterol metabolic process |
GO_0045471 | Biological process | response to ethanol |
GO_0015721 | Biological process | bile acid and bile salt transport |
GO_0038183 | Biological process | bile acid signaling pathway |
GO_0071397 | Biological process | cellular response to cholesterol |
GO_0045717 | Biological process | negative regulation of fatty acid biosynthetic process |
GO_0070857 | Biological process | regulation of bile acid biosynthetic process |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0045542 | Biological process | positive regulation of cholesterol biosynthetic process |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0006707 | Biological process | cholesterol catabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0008123 | Molecular function | cholesterol 7-alpha-monooxygenase activity |
GO_0033782 | Molecular function | 24-hydroxycholesterol 7alpha-hydroxylase activity |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
Gene name | CYP7A1 |
Protein name | Cytochrome P450 7A1 (24-hydroxycholesterol 7-alpha-hydroxylase) (EC 1.14.14.26) (CYPVII) (Cholesterol 7-alpha-hydroxylase) (Cholesterol 7-alpha-monooxygenase) (EC 1.14.14.23) |
Synonyms | CYP7 |
Description | FUNCTION: A cytochrome P450 monooxygenase involved in the metabolism of endogenous cholesterol and its oxygenated derivatives (oxysterols) . Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) . Functions as a critical regulatory enzyme of bile acid biosynthesis and cholesterol homeostasis. Catalyzes the hydroxylation of carbon hydrogen bond at 7-alpha position of cholesterol, a rate-limiting step in cholesterol catabolism and bile acid biosynthesis . 7-alpha hydroxylates several oxysterols, including 4beta-hydroxycholesterol and 24-hydroxycholesterol . Catalyzes the oxidation of the 7,8 double bond of 7-dehydrocholesterol and lathosterol with direct and predominant formation of the 7-keto derivatives . . |
Accessions | ENST00000301645.4 P22680 |